One of the biggest challenges faced by biomedicine is the development of more selective and efficient cancer treatments. In 2018, 1.7 million people died from lung cancer worldwide, a number equivalent to the population of Barcelona. The high mortality rate of lung cancer reflects the need for the development of treatments that are more efficient.
Read More
Health Rss 